4948475

Source:http://linkedlifedata.com/resource/pubmed/id/4948475

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006213, umls-concept:C0027932, umls-concept:C0040616, umls-concept:C0877971, umls-concept:C1280500, umls-concept:C1457887, umls-concept:C1514811, umls-concept:C1561577, umls-concept:C1706462
pubmed:issue	3
pubmed:dateCreated	1972-8-10
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372774
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Benzazepines, http://linkedlifedata.com/resource/pubmed/chemical/Tranquilizing Agents
pubmed:status	MEDLINE
pubmed:issn	0015-5721
pubmed:author	pubmed-author:KishimotoAA, pubmed-author:MajimaKK, pubmed-author:NakaoTT, pubmed-author:OguraCC, pubmed-author:OkumaTT
pubmed:issnType	Print
pubmed:volume	25
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	181-93
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:4948475-Administration, Oral, pubmed-meshheading:4948475-Adolescent, pubmed-meshheading:4948475-Adult, pubmed-meshheading:4948475-Anxiety Disorders, pubmed-meshheading:4948475-Benzazepines, pubmed-meshheading:4948475-Clinical Trials as Topic, pubmed-meshheading:4948475-Female, pubmed-meshheading:4948475-Humans, pubmed-meshheading:4948475-Hyperkinesis, pubmed-meshheading:4948475-Hypochondriasis, pubmed-meshheading:4948475-Hypotension, pubmed-meshheading:4948475-Hysteria, pubmed-meshheading:4948475-Male, pubmed-meshheading:4948475-Middle Aged, pubmed-meshheading:4948475-Obsessive-Compulsive Disorder, pubmed-meshheading:4948475-Phobic Disorders, pubmed-meshheading:4948475-Tranquilizing Agents, pubmed-meshheading:4948475-Vertigo
pubmed:year	1971
pubmed:articleTitle	Effect of 7-bromo-5-(2-pyridyl)-3H-1, 4-benzodiazepine-2(1H)-one, bromazepam (Ro 5-3350), a new minor tranquilizer, on psychoneurosis with special reference to the obsessive-compulsive symptoms.
pubmed:publicationType	Journal Article, Clinical Trial